Pu J, Yu Q, Yin Z, Zhang Y, et al. The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese
adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial. Vaccine 2021 Apr 9. pii: S0264-410X(21)00431.
PMID: 33875266